The novel treatment of the medication represents a significant breakthrough in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide925628.bluxeblog.com/74479223/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment